These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34685771)

  • 1. Unexpected Implication of SRP and AGO2 in Parkinson's Disease: Involvement in Alpha-Synuclein Biogenesis.
    Hernandez SM; Tikhonova EB; Baca KR; Zhao F; Zhu X; Karamyshev AL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of α-synuclein in Parkinson's disease.
    Choong CJ; Mochizuki H
    Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
    García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
    Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
    Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
    Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.
    Höfs L; Geißler-Lösch D; Wunderlich KM; Szegö EM; Van den Haute C; Baekelandt V; Hoyer W; Falkenburger BH
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
    Gründemann J; Schlaudraff F; Haeckel O; Liss B
    Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
    Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
    PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
    Shamoto-Nagai M; Maruyama W; Hashizume Y; Yoshida M; Osawa T; Riederer P; Naoi M
    J Neural Transm (Vienna); 2007; 114(12):1559-67. PubMed ID: 17690948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
    Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
    J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.
    Cai W; Feng D; Schwarzschild MA; McLean PJ; Chen X
    EBioMedicine; 2018 Mar; 29():13-22. PubMed ID: 29433982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.
    Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X
    Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of α-synuclein solubility in living cells using split GFP complementation.
    Kothawala A; Kilpatrick K; Novoa JA; Segatori L
    PLoS One; 2012; 7(8):e43505. PubMed ID: 22927976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
    Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.
    Akrioti E; Karamitros T; Gkaravelas P; Kouroupi G; Matsas R; Taoufik E
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha Synuclein Toxicity and Non-Motor Parkinson's.
    Mazzotta GM; Conte C
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
    Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
    Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.